Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Sera Prognostics Stock Price, Quotes and Forecasts | NASDAQ:SERA | Benzinga

Q: What sector and industry does Sera Prognostics (SERA) operate in?

Sera Prognostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Sera Prognostics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SERA.

Open	$3.89
Close	-
Volume / Avg.	80.69K / 129.61K
Day Range	$3.50 - $3.89
52 Wk Range	3.77 - 12.36
Market Cap	$133.71M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	2.38%
Days to Cover	8.68

Recent News

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the past week and a look at the reasons why and what's next.

Chris Katje

Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.

Avi Kapoor

Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Monday.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.89
Close	-
Volume / Avg.	80.69K / 129.61K
Day Range	$3.50 - $3.89
52 Wk Range	3.77 - 12.36
Market Cap	$133.71M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	2.38%
Days to Cover	8.68

About Sera Prognostics Inc

Sector

Health Care

Industry

Biotechnology

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early pred...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Sera Prognostics (SERA) stock?

You can purchase shares of Sera Prognostics (NASDAQ:SERA) through any online brokerage.

View our list of the best stock brokerages

Who are Sera Prognostics (SERA) competitors?

Other companies in Sera Prognostics’s space includes: Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT), Zentalis Pharma (NASDAQ:ZNTL) and Larimar Therapeutics (NASDAQ:LRMR).

What is the forecast, or price target, for Sera Prognostics (SERA) stock?

Sera Prognostics has a consensus price target of $8.92.

What is the current price for Sera Prognostics (SERA)?

The stock price for Sera Prognostics (NASDAQ: SERA) is $3.55 last updated March 28, 2025 at 1:49 PM EDT.

Does Sera Prognostics (SERA) pay a dividend?

There are no upcoming dividends for Sera Prognostics.

When is Sera Prognostics (NASDAQ:SERA) reporting earnings?

Sera Prognostics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Sera Prognostics (SERA) going to split?

There is no upcoming split for Sera Prognostics.

What sector and industry does Sera Prognostics (SERA) operate in?

Sera Prognostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Sera Prognostics Stock Price, Quotes and Forecasts

Sera Prognostics (SERA) Forecast